All of these studies are hypothesis-generating and await confirmation in RCTs. According to Lane, the rationale for GLP-1 receptor agonists in lupus stems from the drugs demonstrating anti-inflammatory properties, potentially by inhibiting the NF-B pathway, which plays a crucial role in inflammation
Semaglutide commonly causes gastrointestinal side effects including nausea, vomiting, and diarrhea, particularly during dose escalation
[,] The bioinformatic analysis performed in this study clearly showed that L-carnitine might promote oxidation-associated cell apoptosis and production of hormones and improve glucose and lipid metabolism in the ovaries and whole body through the 6 identified core targets
Your first month results might be modest, especially if you are on prednisone
Additionally, some patients may not have completed the full dose escalation schedule, remaining at intermediate doses that are less effective for weight management
The short answer is yes, but the switch must be carefully managed under a healthcare professionals guidance
